AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 285: R1421-R1429, 2003. First published August 28, 2003; doi:10.1152/ajpregu.00702.2002
0363-6119/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/R1421    most recent
00702.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jonas, C. R.
Right arrow Articles by Ziegler, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jonas, C. R.
Right arrow Articles by Ziegler, T. R.

APPETITE, OBESITY AND METABOLISM

Glutamine and KGF each regulate extracellular thiol/disulfide redox and enhance proliferation in Caco-2 cells

Carolyn R. Jonas,1 Li H. Gu,1 Yvonne S. Nkabyo,2 Yanci O. Mannery,2 Nelly E. Avissar,3 Harry C. Sax,3 Dean P. Jones,4,5 and Thomas R. Ziegler1,5

Departments of 1Medicine and 4Biochemistry, 2Graduate Program in Molecular and Systems Pharmacology and 5Center for Clinical and Molecular Nutrition, Emory University School of Medicine, Atlanta, Georgia 30322; and 3Department of Surgery, University of Rochester Medical Center, Rochester, New York 14642

Submitted 13 November 2002 ; accepted in final form 27 August 2003


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Glutamine (Gln) and keratinocyte growth factor (KGF) each stimulate intestinal epithelial cell growth, but regulatory mechanisms are not well understood. We determined whether Gln and KGF alter intra- and extracellular thiol/disulfide redox pools in Caco-2 cells cultured in oxidizing or reducing cell medium and whether such redox variations are a determinant of proliferative responses to these agents. Cells were cultured over a physiological range of oxidizing to reducing extracellular thiol/disulfide redox (Eh) conditions, obtained by varying cysteine (Cys) and cystine (CySS) concentrations in cell medium. Cell proliferation was determined by 5-bromo-2-deoxyuridine (BrdU) incorporation. Gln (10 mmol/l) or KGF (10 µg/l) did not alter BrdU incorporation at reducing Eh (-131 to -150 mV), but significantly increased incorporation at more oxidizing Eh (Gln at 0 to -109 mV; KGF at -46 to -80 mV). Cellular glutathione/glutathione disulfide (GSH/GSSG) Eh was unaffected by Gln, KGF, or variations in extracellular Cys/CySS Eh. Control cells largely maintained extracellular Eh at initial values after 24 h (-36 to -136 mV). However, extracellular Eh shifted toward a narrow physiological range with Gln and KGF treatment (Gln -56 to -88 mV and KGF -76 to -92 mV, respectively; P < 0.05 vs. control). The results indicate that thiol/disulfide redox state in the extracellular milieu is an important determinant of Caco-2 cell proliferation induced by Gln and KGF, that this control is independent of intracellular GSH redox status, and that both Gln and KGF enhance the capability of Caco-2 cells to modulate extremes of extracellular redox.

cysteine; glutathione; intestine; oxidation-reduction; keratinocyte growth factor


INTRACELLULAR CONCENTRATIONS of low molecular weight thiols and the redox state of intra- and extracellular thiol pools are known to regulate cellular proliferation, differentiation, and apoptosis (17, 18, 22, 33-35). The cysteine (Cys)/cystine (CySS) couple is the predominant extracellular low molecular weight thiol/disulfide redox pool (23-24). In HT-29 cells, Cys depletion in cell medium causes a rapid and marked oxidation of intracellular glutathione/glutathione disulfide (GSH/GSSG) redox, which is rapidly reversed with repletion of Cys (32). In rat jejunum, luminal GSSG is partially reduced to GSH by a mechanism using Cys released directly from the epithelium or derived from breakdown of GSH released from the epithelium (8). We recently showed that extracellular Eh regulates both spontaneous and EGF- or insulin-like growth factor-I (IGF-I)-stimulated Caco-2 cell proliferation (22). Furthermore, these specific growth factors enhanced the ability of Caco-2 cells to return the extracellular Cys/CySS pool toward a physiological range when initially cultured in oxidizing or reducing Cys/CySS Eh (22). Therefore, changes in extracellular Cys/CySS redox status may play a fundamental role in intestinal cell responses to certain guttrophic agents.

GSH, the major low molecular weight intracellular thiol, plays a critical role in maintenance of intracellular thiol/disulfide redox balance in gut and other tissues (25). Decreased concentrations of GSH and/or increased concentration of GSSG, impair cell proliferation in several cell types (17, 18, 25, 34). In human colonic epithelial cell lines, intracellular GSH/GSSG redox potential (Eh) becomes oxidized as cells transition from the proliferative to the differentiated state, either spontaneously in Caco-2 cells (33) or with induction by differentiation inducers in HT-29 cells (26).

A growing number of investigations indicate that supplementation with the amino acid glutamine (Gln) stimulates growth, repair, and barrier function of the gut epithelia (30, 42). Gln is a major respiratory fuel for intestinal mucosal cells in vivo and is required for optimal cell proliferation in vitro (27, 38, 41). The Gln product glutamate is a constituent of GSH; in rats, enteral Gln supplementation increases splanchnic GSH production (4), whereas Gln-enriched nutrition in catabolic animal models increases tissue GSH concentrations (13, 16). Thus control of GSH redox status by Gln represents a potential mechanism for the proliferative effects of this nutrient in intestinal epithelial cells.

Keratinocyte growth factor (KGF) is an epithelial cell-specific growth factor with marked stimulatory effects on gut mucosal cell lineages (3, 10, 11, 19). We recently found that KGF prevents the decrease in GSH and oxidation of the GSH/GSSG pool in rat intestinal mucosa induced by malnutrition (20). Modulation of GSH redox status by KGF may be an important determinant of the gut-trophic effects of this agent, because redox reactions are known to control growth factor-stimulated cell proliferation (1, 5, 14, 15, 36, 39), and depletion of intracellular GSH inhibits cell proliferation in response to specific growth factors (1, 5, 36).

The current study was designed to test whether treatment with Gln alters extremes of extracellular redox in Caco-2 cells and whether initial extracellular redox conditions determine proliferative responses to this nutrient. In light of our data showing extracellular redox regulation in Caco-2 cells treated with EGF and IGF-I (22), we also compared the effects of Gln with administration of KGF, an epithelial-specific growth factor. Our results show that the thiol/disulfide extracellular redox state is a major determinant of cell proliferation induced by both Gln and KGF. In addition, treatment with both Gln and KGF enhanced the ability of Caco-2 cells to adjust extremes of extracellular redox toward a range similar to that found during health in vivo (23, 24).


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Chemicals. KGF was a gift from Amgen, Thousand Oaks, CA. All other chemicals and reagents were purchased from Sigma (St. Louis, MO).

Cell culture. The Caco-2 cell line was obtained from American Type Culture Collection (ATCC, Gaithersburg, MD) at passage 19. Cells were maintained as monolayer cultures under 5% CO2 at 37°C in MEM and were supplemented with 2 mmol/l Gln, 10 U/ml penicillin and 10 µg/ml streptomycin, and 10% fetal calf serum (GIBCO BRL, Rockville, MD). Cells were passaged every 5 to 7 days (when 80-90% confluent). All experiments outlined below were performed on cells from passages 25 to 32. During serum starvation, cells were cultured in serum-free MEM. Gln was also excluded during serum starvation to limit cell proliferation. There was no visual evidence of cell death (increased number of detached cells, Trypan blue staining) after serum starvation or any of other manipulations performed in this study.

Extracellular thiol/disulfide redox conditions. Experiments were designed to generate a range of oxidizing to reducing extracellular redox conditions by controlled manipulation of the Cys/CySS redox pool. In our previous studies, the Cys/CySS Eh in plasma of healthy adults was 80 ± 9 mV (24); thus we designed the current in vitro studies to test oxidizing to reducing redox states around this physiological in vivo Eh range. The extracellular thiol pool was altered by varying concentrations of Cys and CySS added to cyst(e)ine-free DMEM. Concentrations for Cys and CySS required to achieve initial redox states (Eh) of 0, -46, -80, -109, -131, and -150 mV were calculated using the Nernst equation: Eh = Eo + RT/2F ln ([CySS]/[Cys]2) (6). Eh (expressed in V or mV) represents the electromotive force relative to a standard hydrogen electrode where R is the gas constant, T is the absolute temperature, F is Faraday's constant, and Eo is the standard electrode potential for the Cys/CySS redox couple.

Concentrations of CySS/Cys added to modified DMEM were as follows (in µmol/l): 99.75:0.5 (0 mV, most oxidizing condition), 98:4 (-46 mV), 93:14 (-80 mV), 80:40 (-109 mV), 60:80 (-131 mV), 10:180 (-150 mV, most reducing condition). All conditions contained the same molar equivalents of Cys. Calculated Eh values included Eo of -0.250 V, accounting for the medium pH adjustment to 7.4 after CyS and CySS addition. This value is in accordance with that reported from studies in the human colonic epithelial cell line HT-29 (26). Medium pH was adjusted to 7.4 after Cys and CySS addition and was filter sterilized before use.

Gln and KGF treatment protocols. Caco-2 cells were plated in 96-well plates at a seeding density of 104 cells/well. After 48 h (~60% confluency), cells were cultured in MEM without serum or Gln for 24 h. Caco-2 cell proliferative responses to different Gln and KGF doses were confirmed using cells treated for the subsequent 24 h in serum-free MEM, with or without increasing concentrations of added Gln or KGF. To determine Caco-2 proliferation responses to altered extracellular Eh alone, cells were similarly serum- and Gln-starved for 24 h and during the subsequent 24 h period cultured in cyst(e)ine-free DMEM (containing 4 mmol/l Gln) with varying amounts of Cys and CySS, as described above. To determine responses to Gln and KGF treatment during altered extracellular thiol/disulfide redox, cells were serum- and Gln-starved for 24 h, and during the subsequent 24-h period cultured in DMEM supplemented with L-Gln [10 mmol/l (total dose) or KGF (10 µg/l)] for 24 h, with or without Cys and CySS additions to give the range of initial Eh values outlined previously. Parallel experiments were conducted in which cells were treated with L-alanine (Ala; 10 mmol/l) to evaluate responses to an amino acid that is not used as a source of ATP production by gut epithelial cells (28).

5-Bromo-2-deoxyuridine incorporation assay. For measurement of 5-bromo-2-deoxyuridine (BrdU) incorporation into DNA, cells were incubated in the presence of BrdU for 2 h. After being labeled, BrdU incorporation was measured with a cell proliferation ELISA (Boehringer Mannheim, Indianapolis, IN). The absorbance from peroxidase reaction with the substrate tetramethylbenzidine (TMB) was measured by a scanning multi-well spectrophotometer at 450 nm (reference wavelength at 650 nm) (Molecular Devices, Sunnyvale, CA). Increases in BrdU incorporation were expressed as a percent of control for all experiments. Controls were cells grown in the 0 mV condition without serum or added Gln or KGF. [3H]thymidine incorporation was used to confirm dose responses to Gln measured using BrdU.

Determination of cellular and extracellular thiols and disulfides by HPLC. Cell medium was added 1:1 to ice-cold 100 g/l perchloric acid, 0.2 mol/l boric acid, and 10 µmol/l {gamma}-glutamyl-glutamate ({gamma}-Glu-Glu) as the internal standard. Cells were rinsed with 500 µl (1x) PBS and then an ice-cold solution (500 µl) containing 50 g/l perchloric acid, 0.2 mol/l boric acid, and 10 µmol/l {gamma}-Glu-Glu was added directly to the cells. Cells were scraped and transferred to microcentrifuge tubes; precipitated protein was separated by centrifugation. GSH, GSSG, Cys, CySS, and the disulfide of Cys and GSH, CySSG, were determined from the acid-soluble supernatant as N,N-bis-dansyl or S-carboxymethyl-N-dansyl derivatives by HPLC with fluorescence detection as described (22, 26). Quantitation was by integration relative to the internal standard, expressed as nanomoles per milligram protein. The Eh values for the intracellular GSH/GSSG and extracellular Cys/CySS (mV) pools were calculated using the Nernst equation with combined constants for a two-electron transfer Eh = Eo + 30 log[(disulfide)/(thiol)2], using Eo = -0.264 mV for GSH/GSSG and -0.250 mV for Cys/CySS, respectively (6, 26).

CySS transport studies. Caco-2 cells were plated in six-well plates at a density of 3 x 105/well as above. After 48 h, cells were cultured in MEM without serum or Gln for 24 h, then incubated at 37°C in oxidizing medium (extracellular Eh = 0 mV) for 20 min. Additional medium (0 mV) containing 2 µCi [35S]CySS (Amersham Biosciences, Piscataway, NJ) and either Gln (10 mmol), KGF (10 µg/l), or no treatment (control), was then added to each well. The cells were incubated for 2-10 min, washed twice in cold PBS, and harvested using 2% Triton-X. An aliquot of cellular material from each well (100 µl) was quantitated by scintillation counting using parallel values obtained from counting of 1 nM of [35S]CySS in each experiment. The rate of CySS transport into cells was normalized to intracellular protein content (37).

Statistical analysis. Results are expressed as means ± SE. Differences in BrdU incorporation, measures of GSH and Cys redox, and CySS transport were compared across groups by one-way ANOVA. Specific treatment effects were compared post hoc using the Fisher's protected least-significant difference test. Data comparisons with P < 0.05 were considered statistically significant.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Gln and KGF induce Caco-2 cell proliferation. Initial experiments were performed to define doses of Gln and KGF required to stimulate Caco-2 cell proliferation. Gln at doses of 1.0, 10, and 100 mmol/l each significantly increased BrdU incorporation by 40-50% compared with control (Fig. 1A). To determine an optimal Gln dose for these experiments, DNA synthesis was also measured using [3H]thymidine incorporation and the same Gln doses. Results showed a similar increase (132%) with 10 mmol/l Gln (P < 0.05). KGF stimulated BrdU incorporation in a threshold dose-related manner (Fig. 1B). No additive or synergistic effect on Caco-2 cell proliferation occurred when cells were cultured in Gln (10 mmol/l) combined with KGF (10 µg/l) (data not shown). On the basis of these data and earlier studies on dose-related intestinal epithelial cell proliferation with Gln (38), doses of 10 mmol/l Gln and 10 µg/l KGF (10 µg/l) were used in subsequent experiments.



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1. Glutamine (Gln) and keratinocyte growth factor (KGF) stimulate 5-bromo-2-deoxyuridine (BrdU) incorporation into Caco-2 cells. Cells were serum and Gln starved for 24 h, then exposed to different doses of Gln (A) or KGF (B) in MEM (serum and Gln free) for 24 h. Cells were incubated with BrdU for 2 h and incorporation measured using ELISA by the absorbance from peroxidase reaction with tetramethylbenzidine (TMB) substrate. Absorbance data are expressed as a percent of control cells (cultured in serum- and Gln-free MEM) and shown as means ± SE. Results represent data from 3 separate experiments, each performed in triplicate. *P < 0.05 vs. control.

 

Caco-2 cell proliferation is modulated by altered extracellular thiol/disulfide redox. Our previous clinical studies indicate that CySS and Cys concentrations in plasma of young healthy adults and in adults with hematologic malignancies are ~50-60 µmol/l CySS and 8-16 µmol/l Cys, respectively (21, 24). These values are considerably less than the 200 µmol/l CySS (400 µmol/l equivalents of Cys) present in standard DMEM. To more closely approximate plasma thiol/disulfide pools and allow for cellular utilization, the experiments were designed with a total concentration in Cys moieties of 200 µmol/l, i.e., [Cys] + 2·[CySS] = 200 µmol/l (4). CySS and Cys concentrations were varied with this constant total pool size to achieve predicted initial extracellular Eh values from 0 to -150 mV. HPLC analysis confirmed these values and that a relevant 100 mV range of extracellular Cys/CySS Eh in cell medium (-36 to -136 mV) was maintained for 24 h after initial culture in redox-modified DMEM alone. Because differences of 10-20 mV in vivo occur in various disease states (21, 23, 32), this range of values (>=100 mV) was sufficient to test whether variations in extracellular Eh affected BrdU incorporation in response to Gln or KGF treatment.

As we previously reported (22), modulation of extracellular thiol/disulfide redox state alone in Caco-2 cells significantly altered DNA synthesis in the absence of serum or Gln (control cells, Fig. 2). As the extracellular Cys/CySS Eh became more reducing (0 to -150 mV), DNA synthesis progressively increased. BrdU incorporation was approximately twofold higher when determined 24 h after culture in the most reducing initial extracellular Eh (-150 mV) compared with incorporation after culture in the most oxidizing extracellular Eh (0 mV).



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2. Extracellular cystine/cysteine (CySS/Cys) Eh regulates Gln-stimulated incorporation of BrdU into Caco-2 cells. Cells were serum and Gln starved for 24 h and then exposed to a range of thiol/disulfide redox potentials (Eh, expressed in mV) in the presence of Gln (10 mmol/l) for 24 h. Initial Eh conditions were obtained by varying medium Cys and CySS concentrations at pH 7.4. After 24 h, cells were incubated with BrdU for 2 h and incorporation measured by the absorbance from peroxidase reaction with TMB substrate using ELISA. Absorbance data are expressed as percent of control (0 mV) and shown as means ± SE. Results represent data from 3 separate experiments, each done in triplicate. *P < 0.05 for Gln-treated cells vs. control cells cultured at the same Eh. aP < 0.05 vs. control cells cultured at 0 mV; bP < 0.05 vs. all other control cells.

 

Dependence of Gln-induced Caco-2 cell proliferation on extracellular thiol/disulfide redox. At initial Eh of -131 and -150 mV, the most reducing extracellular thiol/disulfide redox conditions, Gln supplementation did not alter BrdU incorporation compared with control values (Fig. 2). However, Gln supplementation significantly increased cell proliferation when cells were cultured at more oxidizing initial medium redox conditions. Cells cultured in the most oxidizing extracellular Eh (0 and -46 mV) exhibited the greatest stimulation of DNA incorporation with Gln supplementation (2.5-fold increase compared with respective control values; Fig. 2). An intermediate, but still significant, increase in Caco-2 proliferation occurred at initial Eh conditions of -80 and -109 mV (1.7- and 1.6-fold increase, respectively). Thus treatment with 10 mmol/l Gln resulted in different pattern of Caco-2 cell proliferation than observed in control cells cultured at the same medium Eh.

To test whether results with Gln could be reproduced with an amino acid not used for energy by gut epithelial cells, parallel experiments were performed at initial extracellular Eh conditions of 0 mV, -80 mV, and -150 mV with Ala treatment (10 mmol/l). In contrast to the proliferative responses induced with equimolar concentrations of Gln (Fig. 2), Ala did not stimulate Caco-2 proliferation vs. control values at any of the initial extracellular Eh conditions (0 mV, 129 ± 17; -80 mV, 135 ± 15; and -150 mV, 159 ± 28; P = not significant).

Effects of extracellular thiol/disulfide redox on KGF-induced Caco-2 cell proliferation. We performed parallel studies using KGF to determine whether Caco-2 cell responses to the nutrient Gln are similar to those after treatment with KGF. Cells were treated with KGF over the same range of Eh as used in the Gln supplementation studies. At initial Eh conditions of -109, -131, and -150 mV, KGF treatment did not alter BrdU incorporation compared with control values (Fig. 3). However, KGF stimulated DNA synthesis at the most oxidizing extracellular thiol redox states (1.7-fold stimulation at 0 mV, P < 0.06 and 1.9- and 2.0-fold stimulation at -46 mV and -80 mV Eh, respectively, each P < 0.05). The pattern of KGF-induced cell proliferation by changes in extracellular redox was thus similar to that observed with Gln supplementation (stimulation at more oxidizing states, no change at the most reducing states).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3. Extracellular CySS/Cys Eh regulates KGF-stimulated Caco-2 cell proliferation. Cells were serum and Gln starved for 24 h and then exposed to a range of thiol/disulfide redox potentials (Eh, expressed in mV) in the presence of KGF (10 µg/l) for 24 h. Initial Eh conditions were obtained by varying medium Cys and CySS concentrations at pH 7.4. After 24 h, cells were incubated with BrdU for 2 h and incorporation measured by the absorbance from peroxidase reaction with TMB substrate using ELISA. Absorbance data are expressed as percent of control (0 mV) and shown as means ± SE. Results represent data from 3 separate experiments, each done in triplicate. *P < 0.05 for KGF-treated cells vs. control cells cultured at the same Eh. aP < 0.05 vs. control cells cultured at 0 mV; bP < 0.05 vs. all other control cells.

 

Intracellular thiols and disulfides during Gln- and KGF-stimulated Caco-2 cell proliferation. GSH, GSSG, Cys, and CySS content in Caco-2 cells was analyzed by HPLC to determine whether the redox state of intracellular thiol antioxidants was changed in response to varied extracellular Eh, in the presence or absence of Gln and KGF. The initial extracellular Eh conditions 0, -80, and -150 mV did not affect cellular GSH or GSSG concentrations or GSH/GSSG Eh at 24 h in the absence of Gln or KGF (Table 1). These data indicate that changes in extracellular Cys/CySS that influence Caco-2 cell BrdU incorporation do not cause a concomitant change in intracellular GSH/GSSG redox. In control cells, Cys concentrations were below the limit of HPLC detection (<0.017 mmol/l) at each of the initial extracellular Cys/CySS Eh conditions, whereas CySS concentrations did not significantly change (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. Effects of variation in extracellular Cys/CySS redox state (Eh) and addition of KGF and glutamine on intracellular GSH, GSSG, GSH/GSSG Eh, Cys, and CySS in Caco-2 cells

 

As in control cells, Gln supplementation at initial extracellular Eh of 0, -80, or -150 mV did not alter intracellular GSH redox (Table 1). Intracellular GSH/GSSG redox examined within each of the three Eh conditions was not different with Gln supplementation or KGF treatment at 0 mV (i.e., GSH, GSSG, or GSH/GSSG Eh). At both -80 mV and -150 mV, Gln supplementation and KGF treatment were each associated with a modest decrease in cellular GSH concentration vs. control values (Table 1). However, this was associated with a tendency for GSSG to decrease [not significant (NS)], and cellular GSH/GSSG Eh was ultimately the same as the controls at each extracellular Eh condition (Table 1). In contrast to control cells, intracellular Cys was detectable in cells treated either with Gln or KGF. CySS values were similar to control values across each initial extracellular Eh. Thus, although intracellular Cys/CySS Eh could not be calculated in control cells due to undetectable Cys levels, the increase in Cys with Gln and KGF resulted in an increased ratio of intracellular Cys/CySS relative to control cells at each Eh (Table 1). Thus in these Caco-2 cell models, significant changes in the intracellular GSH/GSSG pool redox did not occur with growth regulation by Gln or KGF at any extracellular Eh condition, but each of these agents appears to increase intracellular Cys and the Cys/CySS ratio.

Glutamine and KGF modulate Caco-2 cell extracellular redox state. Concentration of thiols and the disulfide of GSH plus Cys (CySSG) in cell medium were measured to determine regulation of extracellular Cys/CySS redox over time and with Gln and KGF treatment. In control cells and cells treated with Gln or KGF, a substantial fraction of the total added Cys + CySS was lost from the culture medium at 24 h under all initial redox conditions (Table 2), presumably due to intracellular amino acid transport and support of cell growth-associated protein synthesis and other metabolic pathways (25, 37). In control cells, extracellular Cys/CySS Eh ranged from -36 to -136 mV after 24 h in culture (compared to the initial Eh values ranging from 0 to -150 mV) (Fig. 4). Although still representing a substantial range of oxidized to reduced Eh (100 mV range), this finding indicates that Caco-2 cells have the ability to regulate their extracellular redox milieu when cultured at extremes of oxidizing and reducing conditions (22).


View this table:
[in this window]
[in a new window]
 
Table 2. Thiol and disulfide concentrations in culture medium with variation in Cys/CySS redox state (Eh) during glutamine or KGF treatment

 


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4. Caco-2 cells regulate CySS/Cys Eh in the extracellular medium with either Gln supplementation or KGF treatment. Cells were serum and Gln starved for 24 h and then exposed to a range of thiol/disulfide redox potentials (Eh;0, -80 and -150 mV) in the presence of no additives [control (Con)], Gln (10 mmol/l), or KGF (10 µg/l) for 24 h. Initial Eh conditions were obtained by varying medium Cys and CySS concentrations at pH 7.4. The measured Eh of the Cys/CySS pool in Caco-2 cell medium was calculated using the Nernst equation and HPLC-derived Cys and CySS concentrations. Data are shown as means ± SE. Error bars are smaller than symbol size when not apparent. Results represent data from 3 separate experiments, each done in triplicate. *P < 0.05 vs. the 0 mV condition and {dagger}P < 0.05 vs. the -150 mV condition within individual treatments (control, Gln, or KGF). aP < 0.05 vs. both Gln and KGF-treated cells cultured at the same initial Eh.

 

The addition of either Gln or KGF resulted in marked shifts in the extracellular redox environment to values closer to that found for Cys/CySS redox in human plasma (approximately -80 mV) (23, 24). Extracellular redox with Gln supplementation at 24 h was -56 mV compared with the initial Eh of 0 mV and -88 mV compared with initial Eh of -150 mV, respectively (Fig. 4). Similarly, with KGF treatment, extracellular redox at 24 h was -76 mV compared with initial Eh of 0 mV and -92 mV compared with initial Eh of -150 mV, respectively (Fig. 4). Eh values with both Gln and KGF were similar at the three initial redox conditions and were significantly different at 24 h than the corresponding control values (Fig. 4).

Because GSH was not initially present in the culture medium, measurable concentrations of GSH and mixed disulfide CySSG (GSH equivalents) in medium after 24 h are an index of GSH release from the Caco-2 cells. In all treatment groups, the extracellular GSH concentration was significantly higher in cells cultured in more oxidizing initial medium Eh (0 mV and -80 mV) compared with cells cultured in the most reducing initial medium Eh (-150 mV); CySSG concentrations exhibited a similar pattern (Table 2). This suggests that increased GSH release occurs after 24 h of culture at the 0 and -80 mV conditions relative to the -150 mV condition, because concentrations of both GSH and CySSG in medium were similar in control cells and Gln- and KGF-treated cells across the imposed initial extracellular redox states (Table 2). Thus changes in GSH efflux by Caco-2 cells do not appear to be a mechanism for the control of extracellular redox by Gln or KGF treatment (Fig. 4).

Cys concentrations in the medium increased severalfold from the initial imposed level of 0.5 µmol/l at the 0 mV condition for all treatments; however, this increase was much greater with Gln or KGF treatment relative to controls (Table 2). Conversely, at 0 mV medium, CySS concentration decreased from the initial imposed level of 99.75 µmol/l to a lesser extent with Gln or KGF than in control cells. At the reducing -150 mV condition, cells induced a marked decrease in medium Cys concentrations from the initial imposed level of 180 µmol/l in all groups; however, this decrease was several-fold greater with Gln or KGF treatment relative to control cells. CySS concentrations were similar between groups (Table 2).

The change in total Cys equivalents (Cys + CySS concentrations) in cell medium with Gln and KGF treatment were similar (Table 2). At 0 and -80 mV, a higher concentration of Cys equivalents in cell medium relative to control values was induced by Gln or KGF treatment (i.e., less loss of Cys equivalents with each agent under more oxidizing conditions). At -150 mV, a lower concentration of Cys equivalents in cell medium relative to control values (i.e., greater loss of Cys equivalents with each agent under more reducing conditions) was induced in Gln- or KGF-treated cells.

CySS transport into Caco-2 cells with glutamine and KGF at oxidizing extracellular Cys/CySS redox. We performed transport studies using labeled CySS to examine the potential role of the Cys/CySS shuttle (8, 9) as a mechanism by which Gln and KGF enhance the capacity of Caco-2 cells to modulate an initially oxidizing extracellular Eh. Preliminary experiments at 0 mV demonstrated that inward CySS transport was linear at 2 min under all treatment conditions (control, Gln, and KGF; not shown). At 2 min, treatment with Gln resulted in a 34% increase in CySS transport into the cells that was not statistically significant vs. control values (Fig. 5). Treatment with KGF resulted in a significant 89% increase in inward CySS transport compared with control values (Fig. 5). Values between Gln and KGF treatment were not statistically different.



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 5. CySS transport into Caco-2 cells with Gln and KGF treatment under oxidizing extracellular CySS/Cys Eh conditions. Transport studies using 35S-labeled CySS were performed in Caco-2 cells cultured at 0 mV as outlined in METHODS. At 2 min of incubation, treatment with Gln resulted in a 34% increase in CySS transport into the cells that was not statistically significant vs. control values. Treatment with KGF resulted in a significant 89% increase in inward CySS transport compared with control values. Values between Gln and KGF treatment were not statistically different. Results represent data from 4 separate experiments, each done in duplicate. *P < 0.05 vs. control cells.

 


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
The current data suggest that maintenance of extracellular thiol-disulfide balance is physiologically important in the growth of Caco-2 cells, a human colon cancer-derived epithelial cell line. Our results also demonstrate for the first time that some specific nutrients (Gln) and epithelial cell-specific growth factors (KGF) are important for these cells to modulate extracellular Cys/CySS redox. The largest increase in BrdU incorporation after administration of these agents occurred under the most oxidizing conditions, suggesting that the balance of extracellular redox is a key determinant of proliferation induced by these agents in Caco-2 cells. In addition, when measured 24 h after either Gln supplementation or KGF treatment, the Caco-2 cell demonstrated an ability to modulate both extremes of experimental extracellular redox (oxidizing and reducing) toward a narrow physiological range. Thus the data provide an important link between proliferation and extracellular redox. Because redox status may modulate function of numerous cellular proteins via their disulfide moieties (25) and modification of several membrane-associated and/or intracellular proteins (e.g., receptors, signaling pathways) could affect the proliferative responses to Gln and KGF, the results do not establish a direct or specific relationship. However, the current results are similar to those in our previous study using the growth factors EGF and IGF-I, suggesting that generalized mechanism(s) of growth control are involved (22) and that a common feature involves control of extracellular redox state.

Gln is a preferred respiratory fuel and can contribute to cellular energy supply in intestinal epithelial cells (28, 30, 42). Ala was unable to substitute for Gln in stimulating Caco-2 cell BrdU incorporation. Because Gln is used by gut epithelial cells as a major energy substrate, whereas Ala is not, it is possible that the proliferative response to Gln vs. Ala was a result of energy precursor supply. However, the redox-regulation experiments with Gln, Ala, and KGF were carried out in DMEM that contained a high concentration of the energy substrate glucose (25 mmol/l) with all treatments. Nonetheless, additional experiments to define Caco-2 cell proliferative responses and the ATP/ADP ratio with Gln compared with other fuel substrates under different extracellular redox conditions would be of interest.

The underlying mechanisms for Gln- and KGF-induced effects on proliferation under differing extracellular Cys/CySS redox conditions remain unclear. Given the central role of thiol redox systems in the cell cycle (17, 18, 22, 33-35), the major intracellular and extracellular thiol/disulfide pools were evaluated. Gln and KGF treatment resulted in marked shifts in the redox state of the extracellular Cys/CySS pool and also increased the intracellular Cys/CySS ratio (in particular Cys concentrations) vs. control conditions. In contrast, no changes in the intracellular GSH/GSSG thiol-disulfide pool were observed. The GSH/GSSG findings are similar to our previous results using EGF and IGF-I treatment (22) and with the data of Noda et al. (35) in which exogenous Cys and CySS stimulated Caco-2 cell proliferation independent of an increase in cellular GSH.

The reason for the lack of correlation between altered DNA synthesis rates and intracellular GSH redox indexes remains unclear. Our data are in contrast with other in vitro studies showing a positive association between intracellular GSH levels and rates of cell proliferation (26, 34, 36). We recently found that cellular GSH concentrations decline and GSH/GSSG Eh becomes concomitantly oxidized as Caco-2 cells spontaneously progress from the proliferative to the differentiated phase over 25 days in culture (33). However, the current experiments were carried out in Caco-2 cells during the proliferative phase a few days after plating. In vivo studies in various catabolic rat models show that tissue GSH is increased by Gln supplementation in association with gut-trophic effects (13, 16). Also, in malnourished rats, KGF prevents the decrease in small bowel and colonic mucosal GSH and oxidation of the GSH/GSSG pool concomitant with stimulation of gut mucosal growth (20). Differences between our results and previous in vivo and in vitro studies with regard to cellular GSH may reflect differences in experimental models and cell types studied. It is also possible that small or transient changes in Caco-2 cellular thiol (GSH) status occur during proliferation, but were not detected, perhaps as a result of changes in cell synchronicity or due to the normalization of thiol levels by the time of assay (after 24 h). Others have observed thiol fluctuations limited to the rapid onset of proliferation characterized by transient increases in cellular GSH levels in human bronchial fibroblasts (1). It is thus possible that turnover of intracellular GSH or the GSH/GSSG ratio does play a role in proliferative responses in this cell line that may be detected by evaluation at earlier time points than in our experiments (34). Alternatively, Caco-2 cells may maintain a consistent intracellular redox balance during proliferation, possibly attributed to their transformed cell type. Fibrosarcoma (HT-1080) cells, which similarly exhibit unregulated growth, show no defined shift in intracellular redox balance with proliferation (17).

Control of Caco-2 cell growth by extracellular thioldisulfide balance suggests that a cell membrane-associated redox signal mechanism may be involved. Several lines of investigation demonstrate thiol-linked modulation of membrane-associated proteins or cytosolic and nuclear signaling proteins, including receptor-associated protein complexes, protein tyrosine phosphorylation activity, and intracellular function of transcription factor association and transactivation pathways (2, 14, 15, 39). Recent in vitro studies suggest that intracellular generation of reactive oxygen species, including superoxide or hydrogen peroxide, may play an important role in growth factor signaling (2, 12, 40).

In a previous study, we showed that intact rat jejunum is able to control Eh of luminal (extracellular) thiol-disulfide pools (Cys/CySS and GSH/GSSG) by altering epithelial cell thiol uptake and release in response to added luminal GSSG (8). The response to Gln in the present study is a novel finding regarding nutrient function, indicating that supplementation of a specific nutrient enables cells to modulate extracellular Cys/CySS redox under oxidizing or reducing conditions. Although underlying mechanisms for the ability of Caco-2 cells to control the extracellular redox environment remain unclear, the observed intra- and extracellular concentrations of GSH, GSSG, Cys, CySS and CySSG, and the CySS transport data shed light on possible mechanisms (Table 2). We determined inward transport of CySS into Caco-2 cells to investigate the potential role of the Cys/CySS shuttle (8, 9) as a potential mechanism for correction of initially oxidizing extracellular Eh. With the most oxidizing initial extracellular redox condition, control cell medium was reduced from the initial 0 mV to -36 mV at 24 h; this net reduction of extracellular thiol pools was enhanced by Gln (-56 mV) and KGF (-76 mV) (Fig. 4). GSH transport from cells to medium (Fig. 6A) cannot account for the change in medium Eh given the modest and similar increase in GSH and mixed GSH disulfide (CySSG) concentrations in all experimental groups (Table 2). Gln and KGF treatment increased medium Cys concentrations relative to control without significant decrease in CySS. These treatments (KGF > Gln) also increased CySS transport into the cells (Fig. 5) and were associated with detectable intracellular Cys and an increase in the Cys/CySS ratio (Table 1). Taken together, these data are consistent with activation of the Cys/CySS shuttle (Fig. 6B; Refs. 8, 9) as a control point to reduce the initial oxidizing extracellular Eh.



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 6. Possible mechanisms for reduction of oxidizing extracellular Eh in Caco-2 cells. Under the most oxidizing initial extracellular redox condition (0 mV), cell medium Eh was markedly reduced toward the physiological range with Gln (to -56 mV) or KGF (to -76 mV) (see Fig. 4). GSH transport from the cells to medium (extracellular space) under these redox conditions (A) cannot account for the change given the modest and similar increase in glutathione (GSH) and mixed GSH disulfide (CySSG) concentrations in the control, Gln, and KGF groups (see data Table 2). However, CySS inward transport significantly increased with KGF (by 189% of control, P = 0.013) and tended to increase with Gln (134% of control; not significant) (see Fig. 5). Furthermore, both Gln and KGF increased intra- and extracellular Cys concentrations relative to control cells, without a significant decrease in medium CySS (see data in Table 2). Taken together, these data are consistent with Gln and KGF regulation of the Cys/CySS shuttle mechanism as a factor contributing to normalization of an initial oxidizing Cys/CySS extracellular redox in Caco-2 cells (B; Refs. 8, 9).

 

For the most reducing initial extracellular redox condition (-150 mV), the slight oxidation of the control extracellular thiol pool at 24 h (to -136 mV) was markedly enhanced toward a physiological level of -80 mV by both Gln (-92 mV) and KGF (-88 mV) (Fig. 4). The decrease in the medium GSH concentration at the reducing -150 mV initial redox condition relative to the oxidizing 0 mV condition is consistent with inhibition of cellular GSH release during all experimental treatments, but does not account for the differences between control cells and the Gln- or KGF-treated cells. The decreased extracellular Cys concentrations at 24 h relative to initial imposed Cys concentrations (180 µmol/l) is consistent with increased cellular Cys uptake and utilization/metabolism and was more pronounced in the Gln- and KGF-treated cells.

The lack of changes in CySS concentrations between groups relative to the initial imposed concentration (10 µmol/l) suggests that if plasma membrane thiol oxidases are involved in the Gln and KGF responses (31), Cys is oxidized to products other than CySS. These products could include pyruvate, sulfate, and taurine via upregulation of the Cys dioxygenase pathway, as previously shown to occur with Cys supplementation in rat hepatocytes and enterocytes (7, 29).

In summary, the extracellular thiol/disulfide redox milieu alters endogenous and Gln- and KGF-stimulated DNA synthesis in Caco-2 cells studied during the proliferative phase. Both Gln and KGF reverse the growth inhibitory effects of an oxidizing extracellular environment, potentially by activating the membrane CyS/CySS shuttle (8, 9). In addition, both Gln and KGF treatment enable Caco-2 cells to restore thiol-disulfide redox balance after imposed extremes of oxidizing or reducing extracellular redox. The data suggest that there could be an interaction between Gln- and KGF-activated pathways for cell growth and thiol/disulfide metabolism.


    DISCLOSURES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
This work was supported by National Institutes of Health Grants T32-DK-7732 (to C. R. Jonas); R01-DK-47989 (to H. C. Sax); R01-ES-09047 and R01-ES-011195 (to D. P. Jones); and R01-DK-55850 (to T. R. Ziegler).


    FOOTNOTES
 

Address for reprint requests and other correspondence: T. R. Ziegler, Suite GG-23, General Clinical Research Center, Emory Univ. Hospital, 1364 Clifton Rd., Atlanta, GA 30322 (E-mail: tzieg01{at}emory.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 

  1. Atzori L, Dypbukt JM, Sundqvist K, Cotgreave I, Edman CC, Moldeus P, and Grafstrom RC. Growth-associated modifications of low-molecular-weight thiols and protein sulfhydryls in human bronchial fibroblasts. J Cell Physiol 143: 165-171, 1990.[ISI][Medline]
  2. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18: 775-794, 1995.[ISI][Medline]
  3. Byrne FR, Farrell CL, Aranda R, Rex KL, Brown HL, Flores SA, Danilenko DM, Lacey DL, Gu LH, Ziegler TR, and Senaldi G. Recombinant human keratinocyte growth factor (rHuKGF) ameliorates disease symptoms in the DSS and CD4+CD45RBHi T cell transfer models of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 282: G690-G701, 2002.[Abstract/Free Full Text]
  4. Cao Y, Feng Z, Hoos A, and Klimberg VS. Glutamine enhances gut glutathione production. J Parent Enteral Nutr 22: 224-227, 1998.[Abstract]
  5. Clark S and Konstantopoulos N. Sulfhydryl agents modulate insulin- and epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains: differential effects on basal versus activated receptors. Biochem J 292: 217-223, 1993.[Medline]
  6. Clarke WM. The standard hydrogen half-cell and the standardization of oxidation-reduction potentials and pH numbers. In: Oxidation-Reduction Potentials of Organic Systems. Baltimore, MD: Waverly, 1960, p. 248-272.
  7. Coloso RM and Stipanuk MH. Metabolism of cyst(e)ine in rat enterocytes. J Nutr 119: 1914-1924, 1989.[Abstract/Free Full Text]
  8. Dahm LJ and Jones DP. Rat jejunum controls luminal thioldisulfide redox. J Nutr 130: 2739-2745, 2000.[Abstract/Free Full Text]
  9. Dahm LJ and Jones DP. Secretion of cysteine and glutathione from mucosa to lumen in rat small intestine. Am J Physiol Gastrointest Liver Physiol 267: G292-G300, 1994.[Abstract/Free Full Text]
  10. Estivariz CF, Jonas CR, Gu LH, Diaz EE, Wallace TM, Pascal RR, Farrell CL, and Ziegler TR. Gut-trophic effests of keratinocyte growth factor in rat small intestine and colon during enteral refeeding. J Parent Enteral Nutr 22: 259-267, 1998.[Abstract]
  11. Estívariz CF, Gu LH, Jonas CR, Gu L, Wallace TM, Pascal RR, Devaney KL, Farrell CL, Podolsky DK, and Ziegler TR. Trefoil peptide expression and goblet cell number in rat intestine: effects of KGF and fasting/refeeding. Am J Physiol Regul Integr Comp Physiol 284: R564-R573, 2003.[Abstract/Free Full Text]
  12. Griendling KK, Sorescu D, Lassegue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000.[Abstract/Free Full Text]
  13. Harward TRS, Coe D, Souba WW, Klingman N, and Seegar JM. Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J Surg Res 56: 351-355, 1994.[ISI][Medline]
  14. Hensley K, Robinson KA, Gabbita SP, Salsman S, and Floyd RA. Reactive oxygen species, cell signaling and cell injury. Free Radic Biol Med 28: 1456-1462, 2000.[ISI][Medline]
  15. Herrlich P and Bohmer FD. Redox regulation of signal transduction in mammalian cells. Biochem Pharmacol 59: 35-41, 2000.[ISI][Medline]
  16. Hong RW, Rounds JD, Helton WS, Robinson MK, and Wilmore DW. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 215: 114-119, 1992.[ISI][Medline]
  17. Hutter DE, Till BG, and Greene JJ. Redox state changes in density-dependent regulation of proliferation. Exp Cell Res 232: 435-438, 1997.[ISI][Medline]
  18. Hwang C and Sinskey AJ. The role of oxidation-reduction potential in monitoring growth of cultured mammalian cells. In: Production of Biologicals from Animal Cells in Culture edited by Spier RE, Griffiths JB, and Meignier B. Oxford, UK: Butter-worth-Heinemann, 1991, p. 548-569.
  19. Johnson WF, DiPalma CR, Ziegler TR, and Farrell CL. Keratinocyte growth factor (KGF) enhances early gut adaptation in a rat model of short bowel syndrome. Vet Surg 29: 17-27, 2000.[ISI][Medline]
  20. Jonas CR, Estivariz CF, Jones DP, Gu LH, and Ziegler TR. Keratinocyte growth factor enhances glutathione redox state in intestinal mucosa during nutritional repletion. J Nutr 127: 1278-1284, 1999.
  21. Jonas CR, Puckett AB, Jones DP, Griffith DP, Szeszycki EE, Bergman GF, Carlson JL, Newman MR, Galloway JR, Blumberg JB, and Ziegler TR. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 72: 181-189, 2000.[Abstract/Free Full Text]
  22. Jonas CR, Ziegler TR, Gu LH, and Jones DP. Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco-2) cell line. Free Radic Biol Med 33: 1499-1506, 2002.[ISI][Medline]
  23. Jones DP, Carlson JL, Mody VC, Cai J, Lynn M, and Sternberg P. Redox state of glutathione in human plasma. Free Radic Biol Med 28: 625-635, 2000.[ISI][Medline]
  24. Jones DP, Mody VC Jr, Carlson JL, Lynn MJ, and Sternberg P Jr. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med 33: 1290-1300, 2002.[ISI][Medline]
  25. Jones DP. Redox potential of the GSH/GSSG couple: assay and biological significance. Methods Enzymol 348: 93-112, 2002.[ISI][Medline]
  26. Kirlin WG, DeLong MJ, Patten EJ, Thompson SA, Diaz D, Kavanagh TJ, and Jones DP. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med 27: 1208-1218, 1999.[ISI][Medline]
  27. Ko TC, Beauchamp RD, Townshend CM, Thompson CM, and Thompson JC. Glutamine is essential for epidermal growth factor-stimulated intestinal cell proliferation. Surgery 114: 147-154, 1993.[ISI][Medline]
  28. Kozar RA, Schultz SG, Hassoun HT, Desoignie R, Weisbrodt NW, Haber MM, and Moore FA. The type of sodium-coupled solute modulates small bowel mucosal injury, transport function and ATP after ischemia/reperfusion injury in rats. Gastroenterology 123: 810-816, 2002.[ISI][Medline]
  29. Kwon YH and Stipanuk MH. Cysteine regulates expression of cysteine dioxygenase and {gamma}-glutamylcysteine in cultured rat hepatocytes. Am J Physiol Endocrinol Metab 280: E804-E815, 2001.[Abstract/Free Full Text]
  30. Labow BI and Souba WW. Glutamine. World J Surg 24: 1503-1513, 2000.[ISI][Medline]
  31. Lash LH and Jones DP. Characterization of the membrane-associated thiol oxidase activity of rat small-intestinal epithelium. Arch Biochem Biophys 225: 344-352, 1983.[ISI][Medline]
  32. Miller LT, Watson WH, Kirlin WG, Ziegler TR, and Jones DP. Oxidation of GSH/GSSG redox state induced by cysteine deficiency in human colon carcinoma HT29 cells. J Nutr 132: 2303-2306, 2002.[Abstract/Free Full Text]
  33. Nkabyo YS, Ziegler TR, Gu LH, and Jones DP. Glutathione and thioredoxin redox during differentiation in a human colon carcinoma (Caco-2) cell line. Am J Physiol Gastrointest Liver Physiol 283: G1352-G1506, 2002.[Abstract/Free Full Text]
  34. Noda T, Iwakiri R, Fujimoto K, and Aw TY. Induction of mild intracellular redox imbalance inhibits proliferation of CaCo-2 cells. FASEB J 15: 2131-2139, 2001.[Abstract/Free Full Text]
  35. Noda T, Iwakiri R, Fujimoto K, Rhoads CA, and Aw TY. Exogenous cysteine and cystine promote cell proliferation in CaCo-2 cells. Cell Prolif 35: 117-129, 2002.[ISI][Medline]
  36. Otto WR, Rao J, Cox HM, Kotzian E, Lee CY, Goodlad RA, Lane A, Gorman M, Freemont PA, Hansen HF, Pappin D, and Wright NA. Effects of pancreatic spasmolytic polypeptide (PSP) on epithelial cell function. Eur J Biochem 235: 64-72, 1996.[ISI][Medline]
  37. Ray EC, Avissar NE, and Sax HC. Methods used to study intestinal nutrient transport: past and present. J Surg Res 108: 180-190, 2002.[ISI][Medline]
  38. Rhoads JM, Argenzio RA, Chen W, Rippe RA, Westwick JK, Cox AD, Berschneider HM, and Brenner DA. L-Glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol Gastrointest Liver Physiol 272: G943-G953, 1997.[Abstract/Free Full Text]
  39. Rigacci S, Iantomasi T, Marraccini P, Berti A, Vincinzini MT, and Ramponi G. Evidence for glutathione involvement in platelet-derived growth-factor-mediated signal transduction. Biochem J 324: 791-796, 1997.[Medline]
  40. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-269, 1995.[Abstract/Free Full Text]
  41. Wiren KE, Larsson J, and Magnusson M. The role of glutamine, serum and energy factors in growth of enterocyte-like cell lines. Int J Biochem Cell Biol 30: 1331-1336, 1998.[ISI][Medline]
  42. Ziegler TR, Bazargan N, Leader LM, and Martindale RG. Glutamine and the gastrointestinal tract. Curr Opin Clin Nutr Metabol Care 3: 355-362, 2000.[Medline]



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Zhu, S. Li, Z. M. Marshall, and A. R. Whorton
A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1012 - C1020.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. A Blanco, T. R Ziegler, B. A Carlson, P.-Y. Cheng, Y. Park, G. A Cotsonis, C. J. Accardi, and D. P Jones
Diurnal variation in glutathione and cysteine redox states in human plasma
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1016 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Ramirez, B. Ramadan, J. D. Ritzenthaler, H. N. Rivera, D. P. Jones, and J. Roman
Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L972 - L981.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/R1421    most recent
00702.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jonas, C. R.
Right arrow Articles by Ziegler, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jonas, C. R.
Right arrow Articles by Ziegler, T. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.